AshfordD., di PietraJ. & LingappaJ. (2004). Adverse events in humans associated with accidental
exposure to the livestock brucellosis vaccine RB51. Vaccine, 22, 3435–3439.
3.
Centers for Disease Control and Prevention
(CDC). Brucellosis web site. Available at: www.cdc.gov/ncidod/dbmd/diseaseinfo/brucellosis_g.htm#recommendations. Refer to: Frequently Asked Questions, Recommendations for Risk Assessment, Post-Exposure Prophylaxis and Follow-up of Laboratory Personnel Exposed to Pathogenic Brucella species, and Frequently Asked Questions about Brucella abortus RB51 Laboratory Exposures.
Centers for Disease Control and
Prevention (CDC). (2007). Potential exposure to
attenuated vaccine strain Brucella abortus RB51 during a laboratory proficiency
test–United States, 2007. Morbidity and Mortality Weekly
Report, 56(50), 1320–1321.
6.
Centers for Disease Control and
Prevention (CDC). (2008a). Update: Potential
exposures to attenuated vaccine strain Brucella abortus RB51 during a laboratory
proficiency test–United States and Canada, 2007. Morbidity and
Mortality Weekly Report, 57(2), 36–39.
7.
Centers for Disease Control and
Prevention (CDC). (2008b). Laboratory-acquired
Brucellosis–Indiana and Minnesota, 2006. Morbidity and Mortality
Weekly Report, 57(2), 39–42.
8.
HardingL., &. ByersK.
B. (2006). Epidemiology
of laboratory-acquired infections. In FlemingD.
O. & HuntD.
L. (Eds.), Biological safety, principles
and practices (4th ed.). Washington,
DC: ASM Press.
